AIA
TMCI icon

Alera Investment Advisors’s Treace Medical Concepts TMCI Stock Holding History

Alera Investment Advisors’s Portfolio TMCI Stock Details TMCI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-13,998
Closed -$93.1K – 311
2024
Q2 		$93.1K Buy
+13,998
New +$113K 0.01% 274

Other funds holding TMCI

AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return
CIBC Private Wealth Group
CIBC Private Wealth Group Atlanta, Georgia $59.2B AUM 20.62% 1-Year Est. Return
GS
Gagnon Securities New York $519M AUM 44.91% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Alera Investment Advisors's TMCI Position: Q3 2024 in Review

Alera Investment Advisors sold out of Treace Medical Concepts (TMCI) in Q3 2024, closing a stake of 13,998 shares — an estimated $93.1K sold.

Alera Investment Advisors first reported a position in TMCI in Q2 2024 and held it in 1 quarter. The position peaked at $93.1K in Q2 2024. 134 funds tracked by Wall St. Rank hold TMCI as of Q3 2024.

  • Alera Investment Advisors reported no remaining Treace Medical Concepts position as of Q3 2024 after selling out during the quarter.
  • Alera Investment Advisors sold 13,998 Treace Medical Concepts shares in Q3 2024, an estimated $93.1K.
  • Alera Investment Advisors first reported a position in Treace Medical Concepts in Q2 2024 and held it in 1 quarter.
  • Alera Investment Advisors's Treace Medical Concepts position peaked at $93.1K in Q2 2024.
  • 134 funds tracked by Wall St. Rank held Treace Medical Concepts as of Q3 2024.

Based on Alera Investment Advisors's 13F filing for Q3 2024, filed 14 Nov 2024.